People | January 20, 2021
Shilpa Medicare CFO resigns
The commercial production in the SML was started in November 1989.
The commercial production in the SML was started in November 1989.
This makes the company among few in India to offer fully integrated, end-to-end ADC drug substance development and manufacturing, encompassing payload synthesis, linker development and manufacturing
With this commissioning, Shilpa Medicare joins a very small group of Indian companies capable of offering end-to-end ADC Drug Substance development and manufacturing
The company said Wegovy hit its first one million prescriptions within 12 weeks of availability
Veteran healthcare leader with extensive experience in hospital operations will drive operational excellence, patient-centric care, and sustainable growth in his new role
Dr. Rishi brings more than 15 years of experience in bioprocess development, microbial fermentation, technology transfer, and biotechnology operations
The move marks one of the most significant coverage expansions yet in obesity care, bringing FDA-approved treatment options further into mainstream insurance plans rather than out-of-pocket reach
Q2 2026 analysis shows expanding approvals, stronger uptake, and a shift toward evidence-driven biosimilar evaluation
Move strengthens footprint in Western India and expands multi-specialty care network
The study is a global, randomized, double-blind, placebo-controlled trial testing GLM101 for phosphomannomutase 2 congenital disorder of glycosylation
Subscribe To Our Newsletter & Stay Updated
